Navigation Links
Taiho Pharmaceutical stellt Zulassungsantrag zur Herstellung und Vermarktung des neuartigen Antitumormittels TAS-102
Date:2/26/2013

misierte Doppelblind-Vergleichsstudie von TAS-102 und einem Placebo. Laut Planung werden insgesamt 800 Patienten aus Japan, Nordamerika, Europa und Australien an dieser globalen klinischen Phase-III-Studie teilnehmen. Die Patientenrekrutierung begann im Juni 2012. Die an der Studie teilnehmenden Patienten leiden an inoperablen, rezidivierenden kolorektalen Karzinomen im fortgeschrittenen Stadium und sind für herkömmliche Chemotherapie unempfänglich (Fluoropyrimidin, Irinotecan, Oxaliplatin, Bevacizumab sowie monoklonale EGFR-Antikörper im Falle von KRAS-Wildtyp-Tumoren). Im Zuge der Vergleichsstudie werden Patienten nach dem Zufallsprinzip TAS-102 oder ein Placebo erhalten, um so die Wirksamkeit und Sicherheit von TAS-102 näher zu untersuchen. Das Gesamtüberleben ist der primäre Endpunkt der Studie. Die wissenschaftlichen Leiter sind Dr. Atsushi Otsu , Leiter des klinischen Entwicklungszentrums am National Cancer Center Hospital East (Japan), Dr. Robert J. Mayer des Dana Farber Cancer Institute (USA) und Dr. Eric Van Cutsem vom Universitätskrankenhaus Gasthuisberg (Belgien).

Informationen zu Taiho Pharmaceutical Co., Ltd.
Taiho Pharmaceutical, eine Tochtergesellschaft der Otsuka Holdings Co., Ltd. (http://www.otsuka.com/en/), ist ein auf Forschung und Entwicklung ausgerichtetes, spezialisiertes Pharmaunternehmen, das sich in erster Linie auf die drei Gebiete Onkologie, Allergien und Immunologie sowie Urologie konzentriert. Die Unternehmensphilosophie spiegelt sich in folgendem Versprechen wider: „Wir streben nach einer Verbesserung der menschlichen Gesundheit und wollen zur Bereicherung der Gesellschaft beitragen." Insbesondere im Bereich Onkologie ist Taiho Pharmaceutical in Japan'/>"/>

SOURCE Taiho Pharmaceutical Co., Ltd.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Taiho Pharmaceutical Submits Application for Approval to Manufacture and Market Novel Antitumor Agent TAS-102
2. Taiho Pharmaceutical présente une demande dhomologation pour la fabrication et la commercialisation du nouvel agent antitumoral TAS-102
3. Taiho Pharmaceutical Announces Start of Global Phase III Clinical Trial in Metastatic Colorectal Cancer with Novel Antitumor Agent TAS-102
4. Jazz Pharmaceuticals Reports Full Year And Fourth Quarter 2012 Financial Results
5. Cadence Pharmaceuticals CEO Ted Schroeder To Present At The Cowen & Company 33rd Annual Health Care Conference In Boston On March 5, 2013
6. Global Pharmaceutical Industry Trends: Procurement Budgets Stay the Same, Marketing Budgets to Experience Slight Decrease
7. Savient Pharmaceuticals to Hold Fourth Quarter and Year-End 2012 Financial Results Conference Call on Tuesday, March 19, 2013
8. Savara Pharmaceuticals Announces Formation of Clinical Advisory Board
9. Isis Pharmaceuticals Initiates Phase 2 Study Of ISIS-CRP Rx In Patients With Atrial Fibrillation
10. UBM Launches PharmaEvolution.com, an Online Peer-to-Peer Network for Pharmaceutical Industry Professionals
11. Alexza Pharmaceuticals Corporate Presentation to Be Webcast at Three Upcoming Investor Conferences
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/3/2015)... A global continuing medical education ... thyroid disorders in Latin America ... dedicated to these diseases.      (Logo: http://photos.prnewswire.com/prnh/20150630/227033) ... Manage Hypertension Online and Manage Thyroid Online ... - combine the world,s top expertise with dynamic ...
(Date:7/3/2015)... 2015  Obsidian HDS, the developer of PharmaShine ( ... the management of data on pharmaceutical and device industry ... includes the 2014 Open Payments General and Research data ... 30. The data disclosed on Open Payments for 2014 ... providers totaling $6.49 billion and is the largest public ...
(Date:7/2/2015)... Pharma Major Lupin Limited ... en ZAO "Biocom" en Rusia bajo ciertas condiciones ... Lupin en el mercado farmacéutico de Rusia que ... como uno de los 10 principales mercados farmacéuticos ... de una década, el mercado farmacéutico ruso registró ...
Breaking Medicine Technology:Combating Three Major Chronic Diseases in Latin America With Medical Education 2New Open Payments (Sunshine Act) Data Now Searchable on PharmaShine 2Lupin adquiere Biocom en Rusia 2Lupin adquiere Biocom en Rusia 3
... Newport Audiology Centers announced that it is relocating ... The new Nashville Operations Center will allow the company ... expand operations across their consumer, business-to-business and workers, compensation ... the opportunities Nashville will bring," said David Gligor, Chief ...
... 25, 2011 The Wound and Hyperbaric ... by the Undersea and Hyperbaric Medical Society (UHMS), the ... that few hospitals and facilities have earned, and identifies ... The super oxygenation offered by hyperbaric treatments can ...
Cached Medicine Technology:Good Samaritan Hospital's Wound and Hyperbaric Institute Receives Accreditation from Undersea and Hyperbaric Medical Society, Recognizing Advanced Care 2Good Samaritan Hospital's Wound and Hyperbaric Institute Receives Accreditation from Undersea and Hyperbaric Medical Society, Recognizing Advanced Care 3
(Date:7/3/2015)... ... July 03, 2015 , ... B. E. Smith, the only ... lead a national chief nursing officer recruitment for Jane Phillips Medical ... healthcare industry, B. E. Smith has recently placed more than 1,000 healthcare executives ...
(Date:7/3/2015)... Lewisville, TX (PRWEB) , ... July 03, 2015 , ... ... in the United States, named Mariah N. Manzanares, MD as the new Medical Director ... the new facility medical director of our Frisco facility,” said Dr. James M. Muzzarelli, ...
(Date:7/2/2015)... (PRWEB) , ... July 02, 2015 , ... sweetFrog Enterprises, ... Mississippi. The opening is the first sweetFrog store located in Mississippi. The premium frozen ... companies in 2014. , The store, located at 104 Railroad Avenue, New Albany, MS ...
(Date:7/2/2015)... ... July 02, 2015 , ... ... structure retrofit project at the University of Minnesota, they knew it would save ... would also be an award-winning choice: the total energy savings after installation was ...
(Date:7/2/2015)... ... July 02, 2015 , ... As Americans celebrate the Fourth of ... skin cancer is on the rise. July is UV Safety Month, and physicians at ... the importance of getting skin checks. Experts say most skin cancers can be found ...
Breaking Medicine News(10 mins):Health News:Jane Phillips Medical Center Retains B. E. Smith to Recruit New Chief Nursing Officer 2Health News:Jane Phillips Medical Center Retains B. E. Smith to Recruit New Chief Nursing Officer 3Health News:First Choice Emergency Room Announces Dr. Mariah N. Manzanares as Medical Director of Frisco, TX Facility 2Health News:First Choice Emergency Room Announces Dr. Mariah N. Manzanares as Medical Director of Frisco, TX Facility 3Health News:sweetfrog Opens First Location in Mississippi 2Health News:Kenall’s TekDek™ Helps University Achieve Award-Winning Energy Savings in Parking Structure Lighting Retrofit 2Health News:Local Physicians Warn of Holiday Health Hazards 2Health News:Local Physicians Warn of Holiday Health Hazards 3Health News:Local Physicians Warn of Holiday Health Hazards 4
... BETHESDA, Md., Jan. 12 Hanger Orthopedic Group, ... joined the organization as Executive Vice President and ... Hanger President and Chief Executive Officer Thomas F. ... identification, development, and execution of new opportunities for ...
... Neale, MC,s event with Rock & Roll Hall of ... nation,s biggest problem: the health of our peopleWASHINGTON, Jan. ... Ball announced today the complete line up of speakers ... History Museum, home of the Hope Diamond. Prominent ...
... Jan. 12 Rite Aid Corporation (Rite Aid) and ... to pay $5 million in civil penalties to settle ... the Department of Justice announced today. In addition to ... its subsidiaries agreed to a compliance plan with the ...
... report genetic match; Ohio distributor recalls two King Nut brands; ... 12 (HealthDay News) -- Lab tests on a tainted tub ... of salmonella that has sickened almost 400 people across the ... report, issued on the Minnesota Department of Health Web site, ...
... from neuropathic pain , The pain that is ... the trauma of amputation, entrapment, and compression, is known ... treatments show limited or no effectiveness. Nerve injury underlying ... immune cells are thought to be contributors to the ...
... ROCHELLE, N.Y., Jan. 12 The ... networking website, Facebook , would be well advised ... Such a policy perpetuates the notion that breastfeeding is ... a misguided and antiquated concept that has no place ...
Cached Medicine News:Health News:Hanger Orthopedic Group Welcomes Vinit Asar as Chief Growth Officer 2Health News:Health for All Inaugural Ball Brings Renowned Speakers and Entertainment to Election's Key Issue 2Health News:Health for All Inaugural Ball Brings Renowned Speakers and Entertainment to Election's Key Issue 3Health News:Rite Aid Corporation and Subsidiaries Agree to Pay $5 Million in Civil Penalties to Resolve Violations in Eight States of the Controlled Substances Act 2Health News:Rite Aid Corporation and Subsidiaries Agree to Pay $5 Million in Civil Penalties to Resolve Violations in Eight States of the Controlled Substances Act 3Health News:Rite Aid Corporation and Subsidiaries Agree to Pay $5 Million in Civil Penalties to Resolve Violations in Eight States of the Controlled Substances Act 4Health News:Minn. Confirms Tainted Peanut Butter Link to Salmonella Outbreak 2Health News:JCI online early table of contents: Jan. 12, 2009 2Health News:JCI online early table of contents: Jan. 12, 2009 3Health News:JCI online early table of contents: Jan. 12, 2009 4Health News:JCI online early table of contents: Jan. 12, 2009 5Health News:Facebook Flack Regarding Breastfeeding Mothers 2
Solid 14 mm blades. Dull finish....
Open 14 mm blades of heavy 1 mm wire. Dull finish. Most popular size or model....
Fenestrated 14 mm blades. Self-locking mechanism. Dull finish....
Solid 16 mm blades. Self-locking mechanism. Dull finish....
Medicine Products: